Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
- Authors: Novikov DV1, Polotskiy BE1, Bogush TA1, Davidov MM1, Ahmedov BB1, Rotobelskaya LE1
-
Affiliations:
- N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
- Issue: Vol 20, No 3 (2018)
- Pages: 43-50
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/29568
- DOI: https://doi.org/10.26442/1815-1434_2018.3.43-50
- ID: 29568
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
D V Novikov
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation
Email: dima-dima.000@mail.ru
аспирант торакального отд-ния торакоабдоминального отд. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
B E Polotskiy
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, проф., вед. науч. сотр. торакального отд-ния торакоабдоминального отд. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
T A Bogush
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationд-р биол. наук, проф., вед. науч. сотр., рук. группы молекулярных маркеров опухолей лаб. экспериментальной диагностики и биотерапии опухолей 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
M M Davidov
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationд-р мед. наук, зав. торакальным отд-нием торакоабдоминального отд. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
B B Ahmedov
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationканд. мед. наук, ст. науч. сотр. торакального отд-ния торакоабдоминального отд. 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
L E Rotobelskaya
N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federationнауч. сотр. рентгенологического отд-ния группы медицинской кибернетики 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23
References
- Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Евразийский онкологический журнал. 2017.
- Sean Blandin Knight, Phil A. Crosbie, Haval Balata et al. Progress and prospects of early detection in lung cancer. Open Biol 2017; 7 (9): 170070. doi: 10.1098/rsob.170070
- Богуш Т.А., Дудко Е.А., Беме А.А. и др. Эстрогеновые рецепторы, антиэстрогены и немелкоклеточный рак легкого (обзор). Биохимия. 2010; 75 (12): 1633-41
- Новиков Д.В., Полоцкий Б.Е., Богуш Т.А. и др. ЭРb в опухолевых клетках у мужчин, радикально оперированных по поводу рака легкого, как прогностический фактор и потенциальная мишень антиэстрогеновой терапии. Медицинский алфавит. 2018; 15 (Т-1): 25-31.
- Chen X.Q, Zheng L.X, Li Z.Y. Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer. J Int Med Res 2017; 45 (1): 51-8. doi: 10.1177/0300060516666229
- Lund-Iversen M, Scott H, Strøm E.H et al. Expression of Estrogen Receptor-a and Survival in Advanced-stage Non-small Cell Lung Cancer. Anticancer Res 2018; 38 (4): 2261-9.
- Jinhua Wang, Yali Xu, Li Li et al. FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer. Cancer Med 2017; 6 (1): 275-87.
- Berardi R, Morgese F, Santinelli A et al. Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex. Oncotarget 2016; 7 (50): 82648-57. doi: 10.18632/oncotarget.12244
- Li W, Tse L.A, Wang F. Prognostic value of estrogen receptors mRNA expression in non-small cell lung cancer: A systematic review and meta-analysis. Steroids 2015; 104:1 29-36.
- Li-Han Hsu, Nei-Min Chu, Shu-Huei Kao. Estrogen, Estrogen Receptor and Lung Cancer. Int J Mol Sci 2017; 18 (8): 1713. doi: 10.3390/ijms18081713
- Liu C.M, Chiu K.L, Chen T.S et al. Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma. Biomed Research International 2015; 642041. PMID: 25692143. doi: 10.1155/2015/642041
- Skjefstad K, Grindstad T, Khanehkenari M.R et al. Prognostic relevance of estrogen receptor alpha, beta and aromatase expression in non-small cell lung cancer. Steroids 2016; 113: 5-13. doi: 10.1016/j.steroids.2016.05.008
- Tanaka K, Shimizu K, Kakegawa S et al. Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma. Am J Transl Res 2016; 8: 81-97.
- Kadota K, Eguchi T, Villena-Vargas J et al. Nuclear estrogen receptor-b expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration. Oncotarget 2015; 6 (29): 27505-18.
- Lund-Iversen M, Scott H, Strøm E.H et al. Expression of Estrogen Receptor-a and Survival in Advanced-stage Non-small Cell Lung Cancer. Anticancer Res 2018; 38 (4): 2261-9.
- Pelekanou V, Anastasiou E, Bakogeorgou E et al. Estrogen receptor-alpha isoforms are the main estrogen receptors expressed in non-small cell lung carcinoma. 2018 Feb 15. pii: S0039-128X(18)30016-3. doi: 10.1016/j.steroids.2018.01.008
- Rodriguez-Lara V, Ignacio G.S et al. Estrogen induces CXCR4 overexpression and CXCR4/CXL12 pathway activation in lung adenocarcinoma cells in vitro. Endocr Res 2017; 42: 219-31.
- Zhao L, Huang S, Mei S et al. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis. Proc Natl Acad Sci U S A 2018; 115 (16): E3673-E3681. doi: 10.1073/pnas.1803291115
- Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014.
- Wu C.T, Chang Y.L, Shih J.Y, Lee Y.C. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers. J Thorac Cardiovasc Surg 2005; 130 (4): 979-86.